These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9331798)

  • 21. Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strain.
    Schulze K; Medina E; Guzmán CA
    Vaccine; 2006 Feb; 24(9):1446-50. PubMed ID: 16289766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-density lipoprotein acts as an opsonin to enhance phagocytosis of group A streptococcus by U937 cells.
    Liu L; Zhou L; Li Y; Bai W; Liu N; Li W; Gao Y; Liu Z; Han R
    Microbiol Immunol; 2015 Jul; 59(7):419-25. PubMed ID: 26094502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.
    Park HS; Cleary PP
    Infect Immun; 2005 Dec; 73(12):7878-86. PubMed ID: 16299278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.
    Beachey EH; Stollerman GH; Johnson RH; Ofek I; Bisno AL
    J Exp Med; 1979 Oct; 150(4):862-77. PubMed ID: 390084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a high-throughput opsonophagocytic assay for the determination of functional antibody activity against Streptococcus pyogenes using bioluminescence.
    Lorenz N; Loh JM; Moreland NJ; Proft T
    J Microbiol Methods; 2017 Mar; 134():58-61. PubMed ID: 28115206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective immunity to the group A Streptococcus may be only strain specific.
    de Malmanche SA; Martin DR
    Med Microbiol Immunol; 1994 Dec; 183(6):299-306. PubMed ID: 7596313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved diagnostic accuracy using monoclonal antibody group A streptococcal carbohydrate.
    Nahm MH; Murray PR; Clevinger BL; Davie JM
    J Clin Microbiol; 1980 Oct; 12(4):506-8. PubMed ID: 6999018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemiluminescence of human neutrophils after interaction with group A streptococci opsonized with antibodies to streptococcal carbohydrate.
    Rüfenacht R; Chase P; Jungi TW; Morell A
    Acta Paediatr Hung; 1988-1989; 29(1-2):125-30. PubMed ID: 3076458
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular and biological characterization of histidine triad protein in group A streptococci.
    Kunitomo E; Terao Y; Okamoto S; Rikimaru T; Hamada S; Kawabata S
    Microbes Infect; 2008 Apr; 10(4):414-23. PubMed ID: 18403236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 32. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development.
    McArthur JD; Walker MJ
    Mol Microbiol; 2006 Jan; 59(1):1-4. PubMed ID: 16359313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The OF characteristics of streptococci group A and immunity to streptococcal infection based on the results of OF and anti-OF tests].
    Krasil'nikov IA; Iontova IM; Beliakova IV; Sobolevskaia AA; Zubov AK; Stepanova TM; Fomina NI; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):26-31. PubMed ID: 2143613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model.
    McArthur J; Medina E; Mueller A; Chin J; Currie BJ; Sriprakash KS; Talay SR; Chhatwal GS; Walker MJ
    Infect Immun; 2004 Dec; 72(12):7342-5. PubMed ID: 15557665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an opsonophagocytic killing assay for group a streptococcus.
    Jones S; Moreland NJ; Zancolli M; Raynes J; Loh JMS; Smeesters PR; Sriskandan S; Carapetis JR; Fraser JD; Goldblatt D
    Vaccine; 2018 Jun; 36(26):3756-3763. PubMed ID: 29776751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.
    Mansour NM; Abdelaziz SA
    Microbiol Immunol; 2016 Aug; 60(8):527-32. PubMed ID: 27301486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group A and group B streptococcal vaccine development. A round table presentation.
    Dale JB; Cleary PP; Fischetti VA; Kasper DL; Musser JM; Zabriskie JB
    Adv Exp Med Biol; 1997; 418():863-8. PubMed ID: 9331789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective immunogenicity of group A streptococcal M-related proteins.
    Dale JB; Niedermeyer SE; Agbaosi T; Hysmith ND; Penfound TA; Hohn CM; Pullen M; Bright MI; Murrell DS; Shenep LE; Courtney HS
    Clin Vaccine Immunol; 2015 Mar; 22(3):344-50. PubMed ID: 25630406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity against Streptococcus pyogenes challenge in mice after immunization with fibronectin-binding protein.
    Terao Y; Okamoto S; Kataoka K; Hamada S; Kawabata S
    J Infect Dis; 2005 Dec; 192(12):2081-91. PubMed ID: 16288371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of M protein in phagocytosis. I. Activity of some enzymes in phagocytic cells during infection with Streptococcus pyogenes in vivo.
    Tylewska S; Hryniewicz W
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):33-43. PubMed ID: 44621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.